Role of Liver Biopsy in the Evaluation of Hepatitis C Virus Infection in HIV Coinfection

Sterling, Richard K.
April 2005
Clinical Infectious Diseases;4/15/2005 Supplement, Vol. 40, pS270
Academic Journal
Hepatitis C virus (HCV) coinfection is common in patients infected with human immunodeficiency virus (HIV), because the viruses share common routes of transmission. With the marked increase in life expectancy of HIV-infected patients associated with the use of highly active antiretroviral therapy, HCV infection has become a significant cause of morbidity and mortality in coinfected patients. As a result, there has been increasing attention to adequate assessment of HCV infection during the last several years. Unlike liver enzymes and HCV RNA levels, which can fluctuate widely and do not correlate with the severity of disease, liver biopsy has become the cornerstone in the evaluation of chronic HCV infection. However, there remain important questions and controversies related to adequately determining the histological severity of liver disease and the role of liver biopsy in HIV-HCV-coinfected patients.


Related Articles

  • Liver Fibrosis Progression Is Related to CD4 Cell Depletion in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus. Puoti, Massimo; Spinetti, Angiola; Putzolu, Valeria; Zaltron, Serena; Carosi, Giampiero; Favret, Maurizio; Gargiulo, Francesco; Donato, Francesco; Callea, Francesco; Bonacini, Maurizio; Govindarajan, Sugantha // Journal of Infectious Diseases;1/1/2001, Vol. 183 Issue 1, p134 

    Presents a study which examined patients with liver biopsy-proven hepatitis C virus infection with and without HIV coinfection to evaluate variables associated with liver fibrosis. Methods; Results; Discussion.

  • Hepatitis C reactivation in patients with chronic infection with genotypes 1 b and 2c: a retrospective cohort study of 206 untreated patients. Rumi, M. G.; de Filippi, F.; la Vecchia, C.; Donalo, M. F.; Gahus, S.; del Ninno, E.; Colombo, M. // Gut;Mar2005, Vol. 54 Issue 3, p402 

    Background: We previously described hepatitis reactivation in two carriers of the hepatitis C virus (HCV) genotype 2c. Aim: To assess the relationship between HCV genotypes and risk of hepatitis reactivation, we studied the course of aminotransferases in patients infected with the two relevant...

  • Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin. Sede, M.; Laufer, N.; Ojeda, D.; Gun, A.; Cahn, P.; Quarleri, J. // Archives of Virology;Sep2013, Vol. 158 Issue 9, p1907 

    Even though new drugs have been approved for treatment of hepatitis C virus (HCV) infection, the risk of drug-drug interactions and concern about overlapping toxicities has hindered the development of studies in HIV/HCV-coinfected individuals. Traditional treatment with pegylated interferon plus...

  • Benefits of Curing Hepatitis C Infection. Marinho, Rui T.; Vitor, Sofia; Velosa, José // Journal of Gastrointestinal & Liver Diseases;Mar2014, Vol. 23 Issue 1, p85 

    The hepatitis C virus (HCV) infection is one of the most important chronic viral infections worldwide and affects 3% of the world population, approximately 170-200 million people. The consequences of chronic infection are liver cirrhosis and hepatocellular carcinoma, which develop in 20-30% of...

  • Prevalence and Incidence of HIV, Hepatitis B Virus, and Hepatitis C Virus Infections Among Males in Rhode Island Prisons. Macalino, Grace E.; Sanford-Colby, Stephanie; Patel, Sarju; Salas, Christopher; Rich, Josiah D.; Vlahov, David; Sabin, Keith // American Journal of Public Health;Jul2004, Vol. 94 Issue 7, p1218 

    Objectives. We evaluated prevalence and intraprison incidence of HIV, hepatitis B virus, and hepatitis C virus infections among male prison inmates. Methods. We observed intake prevalence for 4269 sentenced inmates at the Rhode Island Adult Correctional Institute between 1998 and 2000 and...

  • MicroRNAs, Hepatitis C Virus, and HCV/HIV-1 Co-Infection: New Insights in Pathogenesis and Therapy. Gupta, Archana; Swaminathan, Gokul; Martin-Garcia, Julio; Navas-Martin, Sonia // Viruses (1999-4915);Nov2012, Vol. 4 Issue 11, p2485 

    MicroRNAs (miRNAs) can exert a profound effect on Hepatitis C virus (HCV) replication. The interaction of HCV with the highly liver-enriched miRNA, miR-122 represents one such unique example of viruses having evolved mechanism(s) to usurp the host miRNA machinery to support viral life cycle....

  • HIV: The mixed blessing of interferon. Telenti, Amalio // Nature;7/31/2014, Vol. 511 Issue 7511, p537 

    The article focuses on the role of interferon-stimulated proteins in the treatment for HIV-infected patients by referring to a study by N.G. Sandler and colleagues which reported the benefit of the interferon IFNα2a in preventing systemic viral infection. Topics discussed include discussion...

  • Peginterferon &Alfa;-2a improved the hepatitis C virologic response in concurrent HIV and chronic hepatitis C virus infections. Chung, R.T. // ACP Journal Club;Jan/Feb2005, Vol. 142 Issue 1, p10 

    The article reports that peginterferon &Alfa;-2a improved the hepatitis C virologic response in concurrent HIV and chronic hepatitis C virus infections. More patients in the peginterferon α2a plus ribavirin group than in the interferon α-2a plus ribavirin group had a virologie response...

  • Challenges in the Management of HIV and Hepatitis C Virus Co-infection. Lee, Winston; Dieterich, Douglas // Drugs;2004, Vol. 64 Issue 7, p693 

    Hepatitis C virus (HCV) has become a significant contributor to morbidity and mortality to those infected with HIV since the introduction of highly active antiretroviral therapy (HAART). The presence of HIV clearly has a negative effect on the natural history of HCV, although there is some...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics